Tabitha Moe is a Cardiology physician affiliated with University of Phoenix. OpenAlex indexes 46 publications with 937 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
340 E Palm Ln Ste A175
Phoenix, AZ 850044603
Telephone
602-386-1100Registry record last updated 26 Apr 2018.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202524 payments$44,432openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20254 payments
- Lilly USA, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.4%Beta blocker17.5%Metoprolol Succinate36%Carvedilol26%Metoprolol Tartrate25%Sotalol5%Atenolol4%Nebivolol Hcl2%Propranolol Hcl2%Nadolol1%Part D<11 patientsStatin15.3%Atorvastatin Calcium57%Rosuvastatin Calcium26%Simvastatin9%Pravastatin Sodium7%Lovastatin1%Part D<11 patients+ 21 more classes in this area
Blood & clotting
11.9%Factor Xa inhibitor8.2%Eliquis79%Xarelto21%Part D≥125 patientsP2Y12 inhibitor2%Clopidogrel92%Brilinta8%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
10.3%SGLT2 inhibitor5.6%Jardiance84%Farxiga16%Part D≥111 patientsGLP-1 receptor agonist3.1%Ozempic62%Mounjaro30%Wegovy8%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Survey of Board-Certified Adult Congenital Heart Disease Providers Assessing Workforce Gaps
Current Cardiology Reports
2026 - Congenital uterine anomalies and congenital heart disease: An underappreciated association?
International Journal of Cardiology Congenital Heart Disease
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Nakaji, MD
University of Phoenix
Sherman Harman, MD
University of Phoenix
Lyndsay Willmott, MD
University of Phoenix
Ashish Sadhu, MD
University of Phoenix
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”